An automated microfluidic DNA microarray platform for genetic variant detection in inherited arrhythmic diseases

Area of Science:

• Biotechnology
• Genetics
• Medical Diagnostics

Background:

• Inherited arrhythmic diseases are often caused by genetic variants affecting cardiac sodium channels.
• Current diagnostic methods for these variants can be time-consuming and labor-intensive.

Purpose of the Study:

• To develop an automated microfluidic DNA microarray (AMDM) platform for efficient point mutation detection.
• To enhance specificity and reduce assay time for genetic variant analysis.

Main Methods:

• Development of an AMDM platform integrating microfluidics, automated reagent sequencing, and precise temperature control.
• Implementation of a graphene oxide (GO)-assisted hybridization protocol to improve point mutation specificity.
• Validation using SCN5A gene variants (exons 12 and 17) from patients with long QT and Brugada syndromes.

Main Results:

• The AMDM platform successfully discriminated between wild-type and mutant SCN5A DNA.
• The GO-assisted protocol enhanced point mutation detection specificity by quenching non-specific signals.
• Assay time was reduced to 3 hours, a six-fold improvement over conventional DNA microarrays.

Conclusions:

• The AMDM platform offers a rapid, sensitive, and user-friendly solution for genetic testing.
• This automated system minimizes manual labor and contamination risks.
• Potential for widespread application in medical gene screening for inherited arrhythmic diseases.